SARS-CoV-2 spike antigen-specific B cell and antibody responses in pre-vaccination period COVID-19 convalescent males and females with or without post-covid condition
暂无分享,去创建一个
Jean-François Lucier | L. Premkumar | Y. Durocher | M. Nandi | A. Piché | S. Ramanathan | S. Ilangumaran | A. Menendez | Mozhdeh Namvarpour | S. Lemaire-Paquette | H. Allard-Chamard | C. Rioux-Perreault | A. J. Quenum | Marc-André Limoges | Fjolla Rexhepi | Sara Ali Akbari | Akouavi Julite Irmine Quenum | Mohammad Mobarak H Chowdhury | André Cantin | Simon Lévesque | Isabelle J. Dionne | Alain Piché | M. M. H. Chowdhury
[1] J. Pedrosa,et al. Post-acute sequelae of COVID-19 is characterized by diminished peripheral CD8+β7 integrin+ T cells and anti-SARS-CoV-2 IgA response , 2023, Nature Communications.
[2] J. Fraussen,et al. IgD-CD27- double negative (DN) B cells: origins and functions in health and disease. , 2023, Immunology letters.
[3] C. Goldzweig,et al. Serological response to vaccination in post-acute sequelae of COVID , 2023, BMC Infectious Diseases.
[4] W. Lau,et al. Influenza vaccination reveals sex dimorphic imprints of prior mild COVID-19 , 2023, Nature.
[5] A. Piché,et al. Prevalence of persistent symptoms at least 1 month after SARS-CoV-2 Omicron infection in adults. , 2022, Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada.
[6] A. Piché,et al. SARS-CoV-2 infection outcomes associated with the Delta variant: A prospective cohort study. , 2022, Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada.
[7] Sarah E. Webster,et al. Age-related changes in antigen-specific natural antibodies are influenced by sex , 2023, Frontiers in Immunology.
[8] S. Pittaluga,et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy , 2022, Nature.
[9] J. Arrazola,et al. Multimodal neuroimaging in post-COVID syndrome and correlation with cognition , 2022, Brain : a journal of neurology.
[10] Christopher J. L. Murray,et al. Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021. , 2022, JAMA.
[11] James N. Druckman,et al. Prevalence and Correlates of Long COVID Symptoms Among US Adults , 2022, JAMA network open.
[12] B. Palmer,et al. Autoantibodies elicited with SARS-CoV-2 infection are linked to alterations in double negative B cells , 2022, Frontiers in Immunology.
[13] G. Alter,et al. Persistent circulating SARS-CoV-2 spike is associated with post-acute COVID-19 sequelae , 2022, medRxiv.
[14] T. Ndung’u,et al. HIV skews the SARS-CoV-2 B cell response towards an extrafollicular maturation pathway , 2022, bioRxiv.
[15] A. G. Boef,et al. Sex-Related Differences in the Immune Response to Meningococcal Vaccinations During Adolescence , 2022, Frontiers in Public Health.
[16] D. McGovern,et al. Demographic and clinical characteristics associated with variations in antibody response to BNT162b2 COVID-19 vaccination among healthcare workers at an academic medical centre: a longitudinal cohort analysis , 2022, BMJ Open.
[17] J. Lieberman,et al. FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation , 2022, Nature.
[18] J. Alcorn,et al. SARS-CoV-2 Antibody Response Is Associated with Age and Body Mass Index in Convalescent Outpatients , 2022, The Journal of Immunology.
[19] Paloma Martin,et al. Post-COVID-19 syndrome. SARS-CoV-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-19 , 2022, BMC Infectious Diseases.
[20] C. Carty,et al. Combinatorial analysis reveals highly coordinated early-stage immune reactions that predict later antiviral immunity in mild COVID-19 patients , 2022, Cell Reports Medicine.
[21] M. Peluso,et al. Early clues regarding the pathogenesis of long-COVID , 2022, Trends in Immunology.
[22] M. Puhan,et al. Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome , 2022, Nature Communications.
[23] A. Gingras,et al. A scalable serology solution for profiling humoral immune responses to SARS‐CoV‐2 infection and vaccination , 2022, Clinical & translational immunology.
[24] Inyoul Y. Lee,et al. Multiple early factors anticipate post-acute COVID-19 sequelae , 2022, Cell.
[25] D. Vézina,et al. Temporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimen , 2021, bioRxiv.
[26] Tuba Ozgocer,et al. Analysis of long‐term antibody response in COVID‐19 patients by symptoms grade, gender, age, BMI, and medication , 2021, Journal of medical virology.
[27] M. Peluso,et al. Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection. , 2021, The Journal of infectious diseases.
[28] C. Prudêncio,et al. Assessment of avidity related to IgG subclasses in SARS-CoV-2 Brazilian infected patients , 2021, Scientific Reports.
[29] M. Peluso,et al. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms , 2021, Cell Reports.
[30] B. Mustanski,et al. COVID-19 mRNA Vaccination Generates Greater Immunoglobulin G Levels in Women Compared to Men , 2021, The Journal of infectious diseases.
[31] V. Gant,et al. Long COVID following mild SARS-CoV-2 infection: characteristic T cell alterations and response to antihistamines , 2021, medRxiv.
[32] J. Tang,et al. Rapid tests for quantification of infectiousness are urgently required in patients with COVID-19 , 2021, The Lancet Microbe.
[33] A. Mehta,et al. Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells , 2021, medRxiv.
[34] D. Brodie,et al. Post-acute COVID-19 syndrome , 2021, Nature Medicine.
[35] David A. Drew,et al. Attributes and predictors of long COVID , 2021, Nature Medicine.
[36] M. Cecconi,et al. Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study , 2021, European Journal of Nuclear Medicine and Molecular Imaging.
[37] R. Tedder,et al. The Association Between Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Post–COVID-19 Syndrome in Healthcare Workers , 2021, The Journal of infectious diseases.
[38] M. Davenport,et al. Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19 , 2021, Nature communications.
[39] A. Morice,et al. Post-COVID-19 Symptom Burden: What is Long-COVID and How Should We Manage It? , 2021, Lung.
[40] D. Raoult,et al. 18F-FDG brain PET hypometabolism in patients with long COVID , 2021, European Journal of Nuclear Medicine and Molecular Imaging.
[41] Bjoern Peters,et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection , 2021, Science.
[42] A. Meola,et al. Maturation and persistence of the anti-SARS-CoV-2 memory B cell response , 2020, Cell.
[43] A. Casto,et al. Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection , 2020, The Journal of infectious diseases.
[44] M. Rattray,et al. Sex differences in innate anti-viral immune responses to respiratory viruses and in their clinical outcomes in a birth cohort study , 2020, Scientific Reports.
[45] A. Fontanet,et al. Sex Differences in the Evolution of Neutralizing Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 , 2021, The Journal of Infectious Diseases.
[46] M. Shlomchik,et al. Germinal Center and Extrafollicular B Cell Responses in Vaccination, Immunity, and Autoimmunity. , 2020, Immunity.
[47] H. Peckham,et al. Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission , 2020, Nature Communications.
[48] M. Nussenzweig,et al. Evolution of Antibody Immunity to SARS-CoV-2 , 2020, bioRxiv.
[49] O. Laeyendecker,et al. Healthy donor T-cell responses to common cold coronaviruses and SARS-CoV-2. , 2020, The Journal of clinical investigation.
[50] S. Nahnsen,et al. Specific Induction of Double Negative B Cells During Protective and Pathogenic Immune Responses , 2020, bioRxiv.
[51] M. Veldhoen,et al. Seroprevalence of anti‐SARS‐CoV‐2 antibodies in COVID‐19 patients and healthy volunteers up to 6 months post disease onset , 2020, medRxiv.
[52] Kelsey K. Finn,et al. Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19 , 2020, Cell.
[53] L. Carter,et al. Functional SARS-CoV-2-specific immune memory persists after mild COVID-19 , 2020, medRxiv.
[54] D. Raoult,et al. 18F-FDG brain PET hypometabolism in post-SARS-CoV-2 infection: substrate for persistent/delayed disorders? , 2020, European Journal of Nuclear Medicine and Molecular Imaging.
[55] V. Martel-Laferrière,et al. Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals , 2020, mBio.
[56] Angelo Carfì,et al. Persistent Symptoms in Patients After Acute COVID-19. , 2020, JAMA.
[57] C. Rice,et al. Convergent Antibody Responses to SARS-CoV-2 in Convalescent Individuals , 2020, Nature.
[58] Victor G. Puelles,et al. Multiorgan and Renal Tropism of SARS-CoV-2 , 2020, The New England journal of medicine.
[59] W. Chen,et al. Critically ill SARS-CoV-2 patients display lupus-like hallmarks of extrafollicular B cell activation , 2020, medRxiv.
[60] J. McCarthy,et al. Infection-induced plasmablasts are a nutrient sink that impairs humoral immunity to malaria , 2020, Nature Immunology.
[61] Scott A. Jenks,et al. Challenges and Opportunities for Consistent Classification of Human B Cell and Plasma Cell Populations , 2019, Front. Immunol..
[62] S. Klein,et al. The intersection of sex and gender in the treatment of influenza. , 2019, Current opinion in virology.
[63] G. Alter,et al. Sex differences in vaccine-induced humoral immunity , 2018, Seminars in Immunopathology.
[64] Jie Cui,et al. Origin and evolution of pathogenic coronaviruses , 2018, Nature Reviews Microbiology.
[65] G. Gibson,et al. Distinct Effector B Cells Induced by Unregulated Toll‐like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus , 2018, Immunity.
[66] S. Klein,et al. Sex differences in immune responses , 2016, Nature Reviews Immunology.
[67] D. Kelly,et al. Sex-dependent immune responses to infant vaccination: an individual participant data meta-analysis of antibody and memory B cells. , 2016, Vaccine.
[68] G. Olinger,et al. Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study. , 2015, The Lancet. Infectious diseases.
[69] Susan Kovats,et al. Estrogen receptors regulate innate immune cells and signaling pathways , 2015, Cellular immunology.
[70] L. BenMohamed,et al. Gender-Dependent HLA-DR-Restricted Epitopes Identified from Herpes Simplex Virus Type 1 Glycoprotein D , 2008, Clinical and Vaccine Immunology.
[71] J. McCluskey,et al. Immunodominance Hierarchies and Gender Bias in Direct TCD8‐Cell Alloreactivity , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[72] M. Falagas,et al. Sex differences in the incidence and severity of respiratory tract infections. , 2007, Respiratory medicine.
[73] I. Hickie,et al. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study , 2006, BMJ : British Medical Journal.
[74] E. D. Kilbourne. Influenza Pandemics of the 20th Century , 2006, Emerging infectious diseases.
[75] A. Earnest,et al. Pulmonary function and exercise capacity in survivors of Severe Acute Respiratory Syndrome , 2004, European Respiratory Journal.
[76] G. Navis,et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis , 2004, The Journal of pathology.
[77] K. Rajewsky,et al. Human Immunoglobulin (Ig)M+IgD+ Peripheral Blood B Cells Expressing the CD27 Cell Surface Antigen Carry Somatically Mutated Variable Region Genes: CD27 as a General Marker for Somatically Mutated (Memory) B Cells , 1998, The Journal of experimental medicine.
[78] L. Mitchell,et al. Differential antibody responses to rubella virus infection in males and females. , 1992, The Journal of infectious diseases.
[79] D. Tyrrell,et al. The time course of the immune response to experimental coronavirus infection of man , 1990, Epidemiology and Infection.
[80] N. Chiorazzi,et al. Regulation of the immune response by sex hormones. I. In vitro effects of estradiol and testosterone on pokeweed mitogen-induced human B cell differentiation. , 1988, Journal of immunology.
[81] H. Adlercreutz,et al. Sex hormone regulation of in vitro immune response. Estradiol enhances human B cell maturation via inhibition of suppressor T cells in pokeweed mitogen-stimulated cultures , 1981, The Journal of experimental medicine.
[82] R. Serfling,et al. Excess pneumonia-influenza mortality by age and sex in three major influenza A2 epidemics, United States, 1957-58, 1960 and 1963. , 1967, American journal of epidemiology.